Cecilia Stahlhut Espinosa represents life sciences and consumer products companies in Mexico, focusing on health and consumer law matters.
Cecilia has a wealth of experience in regulatory drug matters (pharmaceutical), medical devices, research and development, telemedicine, biotechnology, compliance of new product technologies, and general health regulatory compliance. She has particular experience in the regulation of cosmetics, cannabis, food, alcohol, tobacco, and consumer products in Mexico.
She has participated in the planning and adoption of regulatory strategies for various companies, with respect to product advertising and labeling, product liability, marketing of high-tech products, and launching new products. She advises clients on sophisticated regulatory structures and the restructuring of business models and operations, clinical research projects, approval and marketing authorization pathways, standards for regulated products, compliance, and challenging labeling and advertising issues.
Cecilia has reviewed promotional materials for an extensive range of products and advises clients on promotional activities and compliance of regulations regarding interactions with health care professionals and organizations.
Cecilia was seconded to a major orphan drug company to advise on regulatory framework applicable to orphan drugs and biotechnology as well as the ongoing business activities of the client, including contracts, advertising, marketing, pharmacovigilance, and health-corporate governance.